Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome (Q34576342)

3 August 2017

1 reference

title

Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome (English)

1 reference

3 August 2017

Michael J Robinson

1

1 reference

3 August 2017

Roula B Qaqish

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Psychiatric Clinics of North America

3 August 2017

published in

1 reference

3 August 2017

volume

25

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

149-175

1 reference

Buspirone in drug users with AIDS or AIDS-related complex.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Risperidone for AIDS-associated dementia: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

AIDS and neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Didanosine-induced mania in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Secondary mania in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Mirtazapine for depression in patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Lamotrigine for the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Effects of Methylphenidate in HIV-Related Depression: A Comparative Trial with Desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Adverse neuropsychiatric effects of dopamine antagonist medications. Misdiagnosis in the medical setting

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Efficacy of paroxetine for the treatment of depression in the context of HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Alprazolam-ritonavir interaction: implications for product labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

The entry of antiviral and antiretroviral drugs into the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Does valproate pose a threat to human immunodeficiency virus-infected patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Carbamazepine--indinavir interaction causes antiretroviral therapy failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Evaluation of memantine for neuroprotection in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Possible risks associated with valproate treatment of AIDS-related mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

The use of valproic acid in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Comment: potential risk of valproic acid therapy in patients who are HIV-positive

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

1 reference

7 January 2021

The effect of divalproex sodium on viral load: a retrospective review of HIV-positive patients with manic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Treatment of depressive symptoms in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Use of stimulants in the medically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Possible induction of mania by buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Buspirone-induced mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Pharmacotherapy of HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Secondary mania in patients with HIV infection: are antiretrovirals protective?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

A phase I/II trial of nimodipine for HIV-related neurologic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Depression in patients with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Interactions among drugs for HIV and opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Buspirone-induced mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Are newer antidepressants really "better tolerated"?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

A prospective analysis of 24 episodes of neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Treatment of HIV-related psychotic disorders with risperidone: a series of 21 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Buspirone-induced psychosis in a human immunodeficiency virus-infected man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Significant interactions with new antiretrovirals and psychotropic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

Zidovudine-related mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900056-X

7 January 2021

10.1016/S0193-953X(03)00056-X

Identifiers

DOI

1 reference

release_oimwdlwxpvha5g5njtl76l6zya

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oimwdlwxpvha5g5njtl76l6zya

24 November 2022

mapped directly with Wikidata item

1 reference